Mechanisms of the development of androgen independence in prostate cancer (Q36072079)

12 August 2017

1 reference

title

Mechanisms of the development of androgen independence in prostate cancer (English)

1 reference

12 August 2017

1 reference

4

Colleen Nelson

1 reference

12 August 2017

Alan So

1

1 reference

12 August 2017

Martin Gleave

series ordinal

2

1 reference

12 August 2017

Antonio Hurtado-Col

series ordinal

3

1 reference

12 August 2017

language of work or name

1 reference

27 January 2005

1 reference

12 August 2017

published in

World Journal of Urology

1 reference

12 August 2017

volume

23

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

1-9

1 reference

Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat.

12 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007/S00345-004-0473-1

Active cell death in hormone-dependent tissues

21 January 2018

1 reference

12 December 2020

The biology of hormone refractory prostate cancer. Why does it develop?

1 reference

12 December 2020

Clusterin: Physiologic and pathophysiologic considerations

1 reference

12 December 2020

Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone

1 reference

12 December 2020

Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas

1 reference

12 December 2020

Molecular determinants of resistance to antiandrogen therapy

1 reference

12 December 2020

Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer

1 reference

12 December 2020

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

1 reference

12 December 2020

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor

1 reference

12 December 2020

Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence

1 reference

12 December 2020

Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer

1 reference

12 December 2020

Prostatic involution in men taking finasteride is associated with elevated levels of insulin-like growth factor-binding proteins (IGFBPs)-2, -4, and -5

1 reference

12 December 2020

Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway

1 reference

12 December 2020

Bcl-2 antisense therapy in B-cell malignant proliferative disorders

1 reference

12 December 2020

ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER

1 reference

12 December 2020

Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo

1 reference

12 December 2020

Androgen-repressed messages in the rat ventral prostate

1 reference

12 December 2020

Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays

1 reference

12 December 2020

HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway

1 reference

12 December 2020

Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties

1 reference

12 December 2020

Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process

1 reference

12 December 2020

Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus

1 reference

12 December 2020

Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer

1 reference

12 December 2020

Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB

1 reference

12 December 2020

Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells

1 reference

12 December 2020

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

1 reference

12 December 2020

Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

1 reference

12 December 2020

Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides

1 reference

12 December 2020

Intracellular levels of SGP-2 (Clusterin) correlate with tumor grade in prostate cancer.

1 reference

12 December 2020

Bcl-2 expression in metastatic malignant melanoma. Importance for the therapeutic efficacy of biochemotherapy

1 reference

12 December 2020

Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression

1 reference

12 December 2020

Her-2/neu expression in prostate cancer: high level of expression associated with exposure to hormone therapy and androgen independent disease

1 reference

12 December 2020

Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.

1 reference

12 December 2020

A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy

1 reference

12 December 2020

Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells

1 reference

12 December 2020

Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist

1 reference

12 December 2020

The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens

1 reference

12 December 2020

Androgen receptor gene mutations in human prostate cancer

1 reference

12 December 2020

Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors.

1 reference

12 December 2020

Emerging targets in the AKT pathway for treatment of androgen-independent prostatic adenocarcinoma

1 reference

12 December 2020

Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma.

1 reference

12 December 2020

Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer

1 reference

12 December 2020

Overexpression of clusterin in human breast carcinoma

1 reference

12 December 2020

The development of androgen-independent prostate cancer

1 reference

12 December 2020

Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways

1 reference

12 December 2020

Oblimersen sodium (Genasense bcl-2 antisense oligonucleotide): a rational therapeutic to enhance apoptosis in therapy of lung cancer

1 reference

12 December 2020

Inhibition of progression to androgen-independence by combined adjuvant treatment with antisense BCL-XL and antisense Bcl-2 oligonucleotides plus taxol after castration in the Shionogi tumor model

1 reference

12 December 2020

Adrenal steroids in human prostatic cancer cell lines

1 reference

12 December 2020

Androgen receptor gene alterations and chromosomal gains and losses in prostate carcinomas appearing during finasteride treatment for benign prostatic hyperplasia

1 reference

12 December 2020

Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis

1 reference

12 December 2020

Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.

1 reference

12 December 2020

Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.

1 reference

12 December 2020

Androgen receptor mutations in prostate cancer.

1 reference

12 December 2020

Apolipoprotein J (clusterin) and Alzheimer's disease

1 reference

12 December 2020

Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells

1 reference

12 December 2020

Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway

1 reference

12 December 2020

The IGF axis in the prostate

1 reference

12 December 2020

Constitutive activation of the Ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells

1 reference

12 December 2020

Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models

1 reference

12 December 2020

Insulin-like growth factors and their binding proteins: biological actions

1 reference

12 December 2020

Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer

1 reference

12 December 2020

Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer

1 reference

12 December 2020

Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines

1 reference

12 December 2020

Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation

1 reference

12 December 2020

Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy

1 reference

12 December 2020

Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate

1 reference

12 December 2020

Endocrine withdrawal syndrome and its relevance to the management of hormone refractory prostate cancer

1 reference

12 December 2020

Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes

1 reference

12 December 2020

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

1 reference

12 December 2020

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

1 reference

12 December 2020

Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomas.

1 reference

12 December 2020

Clusterin is a secreted mammalian chaperone

1 reference

12 December 2020

Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome

1 reference

12 December 2020

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

1 reference

12 December 2020

Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell death

1 reference

12 December 2020

Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models

1 reference

12 December 2020

Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin).

1 reference

12 December 2020

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer.

1 reference

12 December 2020

Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer

1 reference

12 December 2020

Akt regulates cell survival and apoptosis at a postmitochondrial level

1 reference

12 December 2020

Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer.

1 reference

12 December 2020

HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway.

1 reference

12 December 2020

Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor

1 reference

12 December 2020

Clusterin Has Chaperone-like Activity Similar to That of Small Heat Shock Proteins

1 reference

12 December 2020

Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model

1 reference

12 December 2020

Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease

1 reference

12 December 2020

SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis

1 reference

12 December 2020

10.1007/S00345-004-0473-1

Identifiers

DOI

1 reference

release_3mhmmsqc3rep7gdy5aiehv27v4

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3mhmmsqc3rep7gdy5aiehv27v4

24 November 2022

mapped directly with Wikidata item

1 reference